- 解決したい課題
- ソリューション
- お知らせとイベント
- ナレッジセンター
- 当社について
For more than 130 years, we've put science and innovation to work - to create more possibilities for more people through the power of health. We adapt and respond quickly to changes in the world around us to deliver better solutions to help people live their best lives.
That commitment remains as we work to ensure continued supply, service and support to our valued customers and healthcare professionals during these times of global uncertainty.
Serology testing is an important next step in combating the
covid-19 pandemic. our automated lab-based test detects the
human antibody response, igG, to the novel coronavirus.
antibody testing provides additional options to test patients
and conduct covid-19 research.
to help with the need for automated, high volume covid-19 testing
abbott has obtained ce marking on its realtime sars-cov-2 assay
for use on the m2000 system. we are accelerating production in an
effort to meet the needs of our customers worldwide.
With increased patient volume at healthcare facilities and the associated scarcity of
resources, evaluating disease severity can help optimize resource utilization by
ensuring that the appropriate level of treatment is provided.
The complete blood count (CBC), one of the most commonly performed tests
in the world, can be a fast and cost-effective way to support patient assessments.
healthcare facilities are being challenged in increased patient
volume and the need for continued monitoring of blood gases
in respiratory care patients. Testing with portable, handheld
i‑STAT analyzers facilitates real-time decisions to optimize care.
abbott is on the frontlines of the covid-19
response with critical tests that will help
protect our communities.
As the situation concerning COVID-19 changes day to day, the following links may help you stay up-to-date on the latest developments.